Alternatives to Umlaut.bio

Developing novel immunotherapies and diagnostics for cancer.

Clinical-stage immunotherapy company developing novel treatments for cancer.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biotechnology company developing novel immunotherapies for cancer.

Developing novel diagnostics to predict patient response to immunotherapy.

A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.